The Global Ketoprofen Market was valued at US$ 36 Million in 2022 and is projected to reach US$ 41 Million by 2029, growing at a Compound Annual Growth Rate (CAGR) of 1.8% during the forecast period. This steady growth is primarily driven by the rising global prevalence of arthritis and chronic pain conditions, coupled with the increasing availability of generic pharmaceuticals and the expansion of healthcare infrastructure in emerging economies.

As the demand for effective analgesics and anti-inflammatory drugs continues to rise, the production of Ketoprofen Active Pharmaceutical Ingredient (API) is concentrated among a few key manufacturers. This blog profiles the Top 10 Companies in the Ketoprofen Market—highlighting the major players who control the global supply chain for this essential medication.

---

🔟 1. SANOFI

Headquarters: Paris, France
Key Offering: Ketoprofen API and Finished Dosage Forms

SANOFI is a global pharmaceutical leader and a significant supplier of Ketoprofen. The company produces high-purity Ketoprofen API for its own branded formulations and for the generic market, adhering to strict Good Manufacturing Practice (GMP) standards across its global manufacturing network.

Strategic Initiatives:

• Extensive R&D in pain management therapeutics

• Robust global supply chain for APIs

• Focus on sustainable and ethical manufacturing practices

Download FREE Sample Report:
Ketoprofen Market – View in Detailed Research Report

---

9️⃣ 2. Boehringer Ingelheim

Headquarters: Ingelheim am Rhein, Germany
Key Offering: Ketoprofen API and Proprietary Formulations

Boehringer Ingelheim is a research-driven pharmaceutical company with a strong presence in the anti-inflammatory drug segment. The company manufactures Ketoprofen for use in its products and for external supply, leveraging its expertise in chemical synthesis and pharmaceutical development.

Strategic Initiatives:

• Investment in advanced manufacturing technologies

• Strategic partnerships with generic drug manufacturers

---

8️⃣ 3. BEC (Biological E. Limited)

Headquarters: Hyderabad, India
Key Offering: Ketoprofen BPC (Bulk Pharmaceutical Chemicals)

Biological E. Limited (BEC) is a prominent Indian pharmaceutical company and a key manufacturer of bulk drugs, including Ketoprofen. The company supplies high-quality Ketoprofen BPC to formulation companies globally, benefiting from cost-effective production capabilities.

Strategic Initiatives:

• Expansion of API manufacturing capacity

• Focus on regulatory compliance for international markets (USFDA, EDQM)

---

7️⃣ 4. Zhejiang Jiuzhou Pharmaceutical Co., Ltd.

Headquarters: Taizhou, Zhejiang, China
Key Offering: Ketoprofen API (Above 99.5% Purity)

Zhejiang Jiuzhou is one of the leading Chinese manufacturers of pharmaceutical intermediates and APIs, including Ketoprofen. The company plays a crucial role in the global supply chain, exporting significant volumes of high-purity Ketoprofen to markets worldwide.

Strategic Initiatives:

• Continuous process optimization for cost efficiency

• Strong export-oriented business model

---

6️⃣ 5. Hubei Xunda Pharmaceutical Co., Ltd.

Headquarters: Wuhan, Hubei, China
Key Offering: Ketoprofen API and Intermediates

Hubei Xunda is a specialized producer of APIs, with Ketoprofen being a key product in its portfolio. The company supplies the domestic Chinese market, which holds about 68% of global consumption, and also serves international clients.

Strategic Initiatives:

• Vertical integration in chemical synthesis

• Investment in environmental and safety standards

Download FREE Sample Report:
Ketoprofen Market – View in Detailed Research Report

---

5️⃣ 6. Solara Active Pharma Sciences Ltd.

Headquarters: Chennai, India
Key Offering: Ketoprofen API

Solara is a focused API company with a diverse portfolio, including anti-inflammatory drugs. While not in the top 5 by the provided data, it is a significant player in the API space, manufacturing Ketoprofen for regulated markets with a strong emphasis on quality systems.

Strategic Initiatives:

• Commissioning of new, modern API facilities

• Strategic focus on controlled substances and niche APIs

---

4️⃣ 7. Arevipharma GmbH

Headquarters: Hamburg, Germany
Key Offering: High-Purity Ketoprofen for European Market

Arevipharma is a German-based supplier of pharmaceutical raw materials, specializing in APIs like Ketoprofen. The company serves as a key distributor and supplier within the European pharmaceutical market, ensuring compliance with strict EMA standards.

Strategic Initiatives:

• Strategic sourcing and quality assurance for EU pharmaceuticals

• Partnerships with Asian manufacturers for supply chain resilience

---

3️⃣ 8. Hangzhou Think Chemical Co., Ltd.

Headquarters: Hangzhou, Zhejiang, China
Key Offering: Ketoprofen and its Chemical Intermediates

Hangzhou Think Chemical is a chemical supplier involved in the production and sale of Ketoprofen. It contributes to the dense manufacturing ecosystem in China’s Zhejiang province, which is a hub for pharmaceutical chemicals.

Strategic Initiatives:

• Leveraging regional manufacturing cluster advantages

• Supplying both domestic and international B2B customers

---

2️⃣ 9. Afton Pharma

Headquarters: Montpellier, France
Key Offering: Ketoprofen API for Generic Medicines

Afton Pharma is a French company specializing in the development, production, and marketing of generic APIs. It supplies Ketoprofen to pharmaceutical companies primarily in Europe and other regions, focusing on competitive pricing and reliable quality.

Strategic Initiatives:

• Focus on the European generic drug market

• Maintaining a diverse portfolio of essential medicine APIs

---

1️⃣ 10. Others (Collective Market Share)

Description: A fragmented landscape of small to medium-sized manufacturers, primarily based in China and India.

This segment comprises numerous smaller chemical and pharmaceutical companies that collectively account for the remaining market share. These players are crucial for regional supply, often providing cost-competitive Ketoprofen BPC to local formulators and exporters.

Market Role:

• Serve localized and niche markets

• Provide competitive pressure on pricing

• Often act as secondary suppliers to larger players

Read Full Report:
Ketoprofen Market – View in Detailed Research Report

---

🌍 Outlook: A Consolidating Market Focused on Quality and Cost

The Ketoprofen market is characterized by maturity and consolidation. While growth is modest, the market dynamics are shifting towards stricter regulatory compliance, supply chain reliability, and cost optimization. The top players are investing in manufacturing excellence to maintain their leadership.

📈 Key Trends Shaping the Market:

• Geographic Dominance: China’s overwhelming share (~68%) of production and consumption underlines its central role in the global Ketoprofen supply chain.

• Regulatory Stringency: Increasing GMP requirements from agencies like the US FDA and EMA are pushing manufacturers towards higher quality standards and continuous process validation.

• Competitive Landscape: The market is highly concentrated, with the top 3 players (SANOFI, Boehringer Ingelheim, BEC) holding approximately 83% of the market share, creating high barriers to entry.

• Product Segmentation: The market is divided by purity grades (Ketoprofen above 99.5% and below 99.5%), with the higher purity segment typically commanding a premium for regulated market applications.

Read Full Report:
Ketoprofen Market – View in Detailed Research Report

The companies profiled above are not just suppliers; they are the foundational pillars of the global supply chain for an essential medicine that provides relief to millions of patients suffering from pain and inflammation worldwide.